MentionFox
Home › Layoffs › Bionano Genomics, Inc.
SEC filings · Form 8-K, Item 2.05

Bionano Genomics, Inc. layoffs and restructuring

Before you join, sell to or invest in Bionano Genomics, Inc.

MentionFox check on Bionano Genomics, Inc.: no red flags found in 4 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/layoffs/bionano-genomics

  • Note: Layoff plan disclosed Sep 2024 (about 84 employees) (filing)

New since last check: Layoff plan disclosed Sep 2024 (about 84 employees) (filing, first seen 14 November 2026).

Check Bionano Genomics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Bionano Genomics, Inc.?

Every exit or restructuring plan Bionano Genomics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 84 employees are affected, about 45% of its workforce, according to Bionano Genomics, Inc.'s latest layoff filing, on September 9, 2024. As of November 14, 2026, Bionano Genomics, Inc. has reported 3 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, September 9, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Lind Global Fund III LP also filed stake reports on 11 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Bionano Genomics, Inc.

Free to see. No signup.

People from Bionano Genomics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Bionano Genomics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings3
Latest, employees84
Latest filing2024-09-09

Bionano Genomics, Inc. reported 3 exit or restructuring plans on Form 8-K under Item 2.05, 2 of 3 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Bionano Genomics have layoffs in 2024? What its filings say

Bionano Genomics, Inc. (CIK 1411690) reported 3 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2024-09-09

Employees affected

As part of the Reduction, the Company expects to reduce its overall headcount by approximately 84 employees, which represents approximately 45% of its full-time employees as of September 3, 2024.

Expected charges

The Company estimates that it will incur total restructuring charges of approximately $0.5 million to $1.0 million, including severance payments in connection with the Plan.

Timing

The Company expects the Reduction will be substantially completed by October 1, 2024.

Form 8-K filed 2024-05-08

Expected charges

The Company has now determined that the Reduction is expected to result in total restructuring charges of approximately $4.6 million, including $3.9 million, comprised primarily of severance payments and wages for the 60-day notice period in accordance with the California Worker Adjustment and Retraining Notification (WARN) Act and $0.2 million in connection with lease terminations.

Timing

The Company expects the Reduction will be substantially completed by June 30, 2024.

Form 8-K filed 2024-03-05

Employees affected

As part of the Reduction, the Company expects to reduce its overall headcount by approximately 110 to 125 employees, which represents approximately 34% to 39% of its full-time employees as of the date of this Current Report on Form 8-K. In addition to the Reduction, Bionano Laboratories intends to phase out the offering of certain testing services related to neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development (the "Products").

Expected charges

These cost-saving measures from the Plan are incremental to the cost saving initiatives previously announced in May 2023 and October 2023 and are expected to provide additional annual savings of operating expenses, of approximately $35.0 to $40.0 million starting in the second half of 2024.

Also on the record for Bionano Genomics, Inc.

DateRecordFigureOur pageSource
October 19, 2026Stake report, Schedule 13G, by Orin Hirschman9.9% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by CVI Investments, Inc.9.9% of the class5%+ stakesSource
June 5, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
May 6, 2026Leadership change: R. Erik Holmlin departs, and 1 more—Leadership changesSource
February 17, 2026Stake report, Schedule 13G/A, by CVI Investments, Inc.9.9% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by Lind Global Fund III LP9.35% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Iroquois Capital Management, LLC4.99% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Lind Global Fund III LP9.9% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Richard Abbe4.99% of the class5%+ stakesSource
November 13, 2025Stake report, Schedule 13G, by Ayrton Capital LLC9.99% of the class5%+ stakesSource
September 24, 2025Stake report, Schedule 13G, by Lind Global Fund III LP9.9% of the class5%+ stakesSource
September 22, 2025Stake report, Schedule 13G, by CVI Investments, Inc.9.9% of the class5%+ stakesSource

Keep reading

More on Bionano Genomics, Inc. and the records around it.

Bionano Genomics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Bionano Genomics, Inc.?

Want the whole picture on Bionano Genomics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Bionano Genomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Bionano Genomics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 15 records.

Tools for this story

Each opens in a new tab, filled in for Bionano Genomics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/bionano-genomics
Last updated 2026-11-14
Bionano Genomics, Inc. layoffs 2024: about 84 jobs (8-K). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/bionano-genomics